CN103285233A - 一种配合护理治疗绝经后骨质疏松症的药物组合物 - Google Patents
一种配合护理治疗绝经后骨质疏松症的药物组合物 Download PDFInfo
- Publication number
- CN103285233A CN103285233A CN2013102385517A CN201310238551A CN103285233A CN 103285233 A CN103285233 A CN 103285233A CN 2013102385517 A CN2013102385517 A CN 2013102385517A CN 201310238551 A CN201310238551 A CN 201310238551A CN 103285233 A CN103285233 A CN 103285233A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- nursing
- postmenopausal osteoporosis
- medical material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000474 nursing effect Effects 0.000 title claims abstract description 21
- 208000001685 postmenopausal osteoporosis Diseases 0.000 title claims abstract description 20
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000012567 medical material Substances 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 241000096284 Gynochthodes officinalis Species 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 10
- 230000002452 interceptive effect Effects 0.000 description 8
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 208000001132 Osteoporosis Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000037182 bone density Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000037171 Hypercorticoidism Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010061223 Ligament injury Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 201000005255 adrenal gland hyperfunction Diseases 0.000 description 1
- 229960004343 alendronic acid Drugs 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310238551.7A CN103285233B (zh) | 2013-06-17 | 2013-06-17 | 一种配合护理治疗绝经后骨质疏松症的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310238551.7A CN103285233B (zh) | 2013-06-17 | 2013-06-17 | 一种配合护理治疗绝经后骨质疏松症的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103285233A true CN103285233A (zh) | 2013-09-11 |
CN103285233B CN103285233B (zh) | 2014-09-24 |
Family
ID=49087122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310238551.7A Active CN103285233B (zh) | 2013-06-17 | 2013-06-17 | 一种配合护理治疗绝经后骨质疏松症的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103285233B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709422A (zh) * | 2005-06-06 | 2005-12-21 | 广东医学院 | 具有促进骨形成的中成药制剂防治骨质疏松症的新用途 |
CN101953993A (zh) * | 2010-08-27 | 2011-01-26 | 高燕 | 一种治疗骨质疏松的中药 |
CN102579817A (zh) * | 2012-03-23 | 2012-07-18 | 临沂大学 | 一种具有治疗骨质疏松功能的中药组合物 |
CN103041129A (zh) * | 2013-02-02 | 2013-04-17 | 崔合芳 | 一种治疗肺炎的中药组合物 |
-
2013
- 2013-06-17 CN CN201310238551.7A patent/CN103285233B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709422A (zh) * | 2005-06-06 | 2005-12-21 | 广东医学院 | 具有促进骨形成的中成药制剂防治骨质疏松症的新用途 |
CN101953993A (zh) * | 2010-08-27 | 2011-01-26 | 高燕 | 一种治疗骨质疏松的中药 |
CN102579817A (zh) * | 2012-03-23 | 2012-07-18 | 临沂大学 | 一种具有治疗骨质疏松功能的中药组合物 |
CN103041129A (zh) * | 2013-02-02 | 2013-04-17 | 崔合芳 | 一种治疗肺炎的中药组合物 |
Non-Patent Citations (1)
Title |
---|
刘广省: "慢性肾功能衰竭的中医药证治研究进展", 《中药材》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103285233B (zh) | 2014-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091234B (zh) | 一种治疗骨伤疾病的中药组合物 | |
CN106938005A (zh) | 一种用于治疗骨质疏松的中药组合物 | |
CN102579708A (zh) | 一种壮阳补肾健肝肺的中药配方 | |
CN102526245B (zh) | 通化丸 | |
CN103285233B (zh) | 一种配合护理治疗绝经后骨质疏松症的药物组合物 | |
CN102657761A (zh) | 一种治疗风湿关节病的贴剂及其制备方法 | |
CN103191315B (zh) | 一种治疗绝经后骨质疏松症的中药 | |
CN105106919A (zh) | 一种保健药酒及其制备方法和应用 | |
CN105477619A (zh) | 一种治疗月经后期的中药组合物 | |
CN105214000A (zh) | 一种治疗皮下脂肪瘤的中药口服液及制备方法 | |
CN104687137A (zh) | 一种鹿茸健脑安神汤料的配方及生产方法 | |
CN103446571B (zh) | 一种祛湿减肥的药物 | |
CN104825802B (zh) | 促进股骨颈骨折内固定术后愈合及减少并发症的中药组方及应用 | |
CN102614380B (zh) | 用于治疗原发性骨质疏松症的中药组合物散剂、片剂、制备方法和保健品 | |
CN102552766B (zh) | 治疗绝经后骨质疏松症的中药、制备方法及给药方式 | |
CN104771634A (zh) | 一种治疗寒凝脉痹型骨质疏松的药物与及其制备方法 | |
CN104758849A (zh) | 一种治疗绝经期骨质疏松症的药物组合物及其制备方法 | |
CN105213793A (zh) | 主治骨质疏松的中药组合物及制法 | |
CN105192833A (zh) | 一种保健饮料及其制备方法 | |
CN104784587A (zh) | 一种治疗内分泌失调型不孕的中药组合物及其制备方法 | |
CN104547989A (zh) | 一种用于治疗脊椎病的藏药膏剂及其使用方法 | |
CN104435883A (zh) | 一种治疗跟痛症的中药制剂 | |
CN104474131B (zh) | 一种用于治疗肝病引起的骨量减少及骨质疏松症的药物 | |
CN104474372A (zh) | 一种用于骨折术后康复医疗的药丸及制备方法 | |
CN104606441A (zh) | 一种治疗肾阳虚衰型绝经后骨质疏松的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Tian Xiaoyan Inventor after: Ling Zongqing Inventor before: Xing Yehong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XING YEHONG TO: TIAN XIAOYAN LING ZONGQING |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: RUDONG COUNTY CHAHE SEWAGE TREATMENT CO., LTD. Free format text: FORMER OWNER: LI WEILI Effective date: 20141225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266200 QINGDAO, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141225 Address after: Rudong County, Jiangsu province 226400 Chahe town Nantong City Xing River Village six groups Patentee after: Rudong County Chahe sewage treatment Co. Ltd. Address before: Jimo City, Shandong province 266200 Jhengtong street Qingdao City No. 20 Patentee before: Li Weili |